Browse All

Current Filters

CLEAR FILTER x

TITLE

Author:

Synergism of Anti-CGRP Monoclonal Antibodies and OnabotulinumtoxinA in the Treatment of Migraine

Author:Hennessy, Elise   Salim, Amira   Biswas, Sudipa   Suneja, Aarushi   Mays, Maryann   Ahmed, Zubair   Mata, Ignacio   

Session Name:P10: Headache: Towards Precision Medicine 1  

Topic:Headache  

Program Number:P10.005  

Author Institution:Cleveland Clinic, Cleveland, OH  

Safety and Efficacy of Concomitant Erenumab and INP104 Use From the Phase 3 STOP 301 Study in Migraine Patients

Author:Ahmed, Zubair   Vann, Robert   Fitzpatrick, Christopher   Ray, Sutapa   Shrewsbury, Stephen   Aurora, Sheena   

Session Name:P13: Headache: Therapeutics 1  

Topic:Headache  

Program Number:P13.002  

Author Institution:Cleveland Clinic, Cleveland, OH  Impel Pharmaceuticals, Seattle, WA  Impel Pharmaceuticals, Fallbrook, CA  

Post-traumatic Seizures in Children with Abusive Head Trauma

Author:Ahmed Khan, Mahjabeen   Goretzke, Sean   Calamur, Nandini   

Session Name:S2: Child Neurology and Developmental Neurology 1  

Topic:Child Neurology and Developmental Neurology  

Program Number:S2.007  

Author Institution:Saint Louis University School Of Medicine, Saint Louis, MO  

Lasting Electrographic Footprint of Familial Hemiplegic Migraine

Author:Ahmed Khan, Mahjabeen   Morris, Cynthia   Goretzke, Sean   

Session Name:P7: Headache: Clinical Investigations in Headache 2  

Topic:Headache  

Program Number:P7.005  

Author Institution:Saint Louis University School Of Medicine, Saint Louis, MO  

NfL Levels Significantly Decrease in Response to Treatment with Patisiran or Vutrisiran in hATTR Amyloidosis with Polyneuropathy

Author:Polydefkis, Michael   Aldinc, Emre   Nienhuis, Hans   Karam, Chafic   Ajroud-Driss, Senda   Sekijima, Yoshiki   Waddington-Cruz, Marcia   Barnes, Jennifer   Nioi, Paul   Ticau, Simina   

Session Name:S14: General Neurology: Emerging Therapies  

Topic:General Neurology  

Program Number:S14.001  

Author Institution:Johns Hopkins University School of Medicine, Baltimore, MD  Alnylam Pharmaceuticals, Cambridge, MA  Amyloidosis Centre of Expertise, University of Groningen, Groningen, Netherlands  University of Pennsylvania, Philadelphia, PA  Northwestern University Feinberg School of Medicine, Chicago, IL  Shinshu University School of Medicine, Matsumoto , Japan  CEPARM, National Amyloidosis Referral Center, University Hospital, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil